» Articles » PMID: 36394667

Expectant Management of Viable Cesarean Scar Pregnancies: a Systematic Review

Overview
Date 2022 Nov 17
PMID 36394667
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Cesarean scar pregnancy (CSP) is a potentially life-threatening disease that has been steadily increasing in prevalence. Pregnancy termination is usually recommended given the risk of life-threatening complications. In some cases, patients refuse to terminate viable CSPs, even after counseling. Recent studies report that, even with a high burden of possible complications and maternal morbidity, many CSPs progress to live, close to term births. The aim of this study is to further demonstrate the natural history of viable cesarean scar pregnancies.

Methods: We conducted a systematic review of original studies reporting cases of expectant management of CSPs with positive fetal heartbeats.

Results: After selection, 28 studies were included in the review, with a total of 398 cases of CSP, 136 managed expectantly and 117 with positive fetal heartbeat managed expectantly. This study confirmed that the majority of patients experience live births, as 78% of patients selected for expectant management experienced live births at or close to term, with 79% developing morbidly adherent placenta, 55% requiring hysterectomy, and 40% having severe bleeding.

Discussion: The optimal management protocol for CSP is still to be defined and more studies are needed to further elucidate this rare but rising disease. Our study provides information on the natural history of untreated CSPs and suggests that termination may not be the only option offered to the patient.

Citing Articles

Correspondence on "Expectant management of viable cesarean scar pregnancies: a systematic review".

OuYang Z, Li H, Yang H Arch Gynecol Obstet. 2023; 308(6):1913-1914.

PMID: 36695899 DOI: 10.1007/s00404-023-06924-x.

References
1.
Timor-Tritsch I, Monteagudo A, Santos R, Tsymbal T, Pineda G, Arslan A . The diagnosis, treatment, and follow-up of cesarean scar pregnancy. Am J Obstet Gynecol. 2012; 207(1):44.e1-13. DOI: 10.1016/j.ajog.2012.04.018. View

2.
Timor-Tritsch I, Monteagudo A, Cali G, Vintzileos A, Viscarello R, Al-Khan A . Cesarean scar pregnancy is a precursor of morbidly adherent placenta. Ultrasound Obstet Gynecol. 2014; 44(3):346-53. DOI: 10.1002/uog.13426. View

3.
Michaels A, Washburn E, Pocius K, Benson C, Doubilet P, Carusi D . Outcome of cesarean scar pregnancies diagnosed sonographically in the first trimester. J Ultrasound Med. 2015; 34(4):595-9. DOI: 10.7863/ultra.34.4.595. View

4.
Shainker S, Coleman B, Timor-Tritsch I, Bhide A, Bromley B, Cahill A . Special Report of the Society for Maternal-Fetal Medicine Placenta Accreta Spectrum Ultrasound Marker Task Force: Consensus on definition of markers and approach to the ultrasound examination in pregnancies at risk for placenta accreta spectrum. Am J Obstet Gynecol. 2021; 224(1):B2-B14. DOI: 10.1016/j.ajog.2020.09.001. View

5.
Timor-Tritsch I, Monteagudo A, Cali G, DAntonio F, Agten A . Cesarean Scar Pregnancy: Patient Counseling and Management. Obstet Gynecol Clin North Am. 2019; 46(4):813-828. DOI: 10.1016/j.ogc.2019.07.010. View